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ChannelsConnexin hemichannels are postulated to form a cell permeabilization pore for the uptake of
ﬂuorescent dyes and release of cellular ATP. Connexin hemichannel activity is enhanced by low
external [Ca2+]o, membrane depolarization, metabolic inhibition, and some disease-causing
gain-of-function connexin mutations. This paper brieﬂy reviews the electrophysiological channel
conductance, permeability, and pharmacology properties of connexin hemichannels, pannexin 1
channels, and purinergic P2X7 receptor channels as studied in exogenous expression systems
including Xenopus oocytes and mammalian cell lines such as HEK293 cells. Overlapping pharmaco-
logical inhibitory and channel conductance and permeability proﬁles makes distinguishing between
these channel types sometimes difﬁcult. Selective pharmacology for Cx43 hemichannels (Gap19 pep-
tide), probenecid or FD&C Blue #1 (Brilliant Blue FCF, BB FCF) for Panx1, and A740003, A438079, or
oxidized ATP (oATP) for P2X7 channels may be the best way to distinguish between these three cell
permeabilizing channel types. Endogenous connexin, pannexin, and P2X7 expression should be con-
sidered when performing exogenous cellular expression channel studies. Cell pair electrophysiolog-
ical assays permit the relative assessment of the connexin hemichannel/gap junction channel ratio
not often considered when performing isolated cell hemichannel studies.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Connexins as hemichannels
Once the second mammalian gap junction protein was cloned
from a rat heart cDNA library, the family of gap junction proteins
was given the name ‘‘connexins’’ [1,2]. The notion that the
undocked hexamer of connexin subunits, historically called a
‘‘connexon’’, could form a functional plasmalemma ion channel,
i.e. a ‘‘hemichannel’’, was ﬁrst reported when attempts to exoge-
nously express the newly cloned lens connexin46 (Cx46) in Xeno-
pus oocytes caused them to lyse [3]. Since the discovery of Cx46
hemichannels, essentially every connexin tested has been induced
to form open hemichannels when presented with favorable condi-
tions of low extracellular calcium ([Ca2+]o) and positive membrane
potentials (Vm) [4]. Whether connexin hemichannels open under
physiological conditions, i.e. negative Vm and 1–2 mM [Ca2+]o, is
less certain. A physiological role for lens Cx46 and Cx50 hemichan-
nels has been proposed since the lens is an avascular tissue and the
microcirculatory homeostasis of the lens depends on nutrient,
electrolyte, and water ﬂow through plasmalemmal channels
[5–7]. No connexin hemichannel has received more attention than
connexin43 (Cx43) hemichannels. Cx43 is the most abundantlyexpressed connexin in the human body, being expressed in essen-
tially every tissue with the exception of certain cell types like
erythrocytes, skeletal muscle ﬁbers, and spermatozoids [1,8]. The
positive correlation between Cx43 expression in macrophage cell
lines and the ability of 100 lM ATP4 to permeabilize their cell
membranes led to the initial speculation that Cx43 hemichannels
form the ATP-release channel in macrophages [9]. However, recent
evidence of ATP permeabilization of Cx43 knockout macrophages
and discovery of the pro-inﬂammatory role of purinergic P2X7
and pannexin 1 (Panx1) channels in immune cells provide sufﬁ-
cient reason to question this interpretation [10–12]. Fluorescent
dye uptake into cultured Novikoff, normal rat kidney (NRK), hu-
man embryonic kidney (HEK) cells, and cortical astrocytes was la-
ter proposed to occur via putative Cx43 hemichannels [13–15]. Of
paramount importance were the observations that metabolic inhi-
bition activated cardiomyocyte and astrocyte Cx43 hemichannel-
mediated dye uptake with eventual loss of membrane integrity
and cell death [14,15]. Astrocyte permeabilization, dye uptake,
and lysis apparently occurred via Cx43 hemichannels since astro-
cytes cultured from conditional or germ-line Cx43 knockout mice
remained impermeable to Lucifer Yellow (LY) dye after 6 h of met-
abolic inhibition. Metabolic inhibition presumably increased Cx43
hemichannel activity by recruitment of hemichannels to the cell
surface, a process that is modulated by Cx43 dephosphorylation
and S-nitrosylation [16]. Protein Kinase C (PKC) activation reduces
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nel conductance and permeability [17]. Thus, there is supportive
evidence for a pathophysiological role of Cx43 hemichannel activa-
tion during metabolic stress, but physiological activation of conn-
exin hemichannels remains controversial.
The pathophysiological role of connexin hemichannel induced
cell membrane permeabilization and death has taken on new
meaning with the association of human disease-linked connexin
mutations to the genesis of abberant hemichannel activity [18].
Of the 21 human connexin genes, 10 have been linked to inherited
human diseases including neuropathies, deafness, skin diseases,
oculodentodigital dysplasia (ODDD), and cardiac arrhythmias
[19,20]. Many connexin mutations result in loss of gap junction
function owing to trafﬁcking deﬁciencies (i.e. gap junction plaque
formation) or channel malformation (non-functional or communi-
cation-deﬁcient channels) [21], whereas abnormal connexin
hemichannel activity should be considered a gain-of-function
mutation. Thus, when considering the functional consequences of
a disease-linked connexin mutation, hemichannel activity should
be considered as a possible mechanism in addition to the dominant
or recessive inhibitory effects of mutant connexin proteins on the
formation of homologous and heterologous wild-type connexin
gap junction channels.
2. Pannexin and purineric P2X7 receptor channels
Pannexin-1, 2, and 3 (Panx1, Panx2, and Panx3) are vertebrate
homologs of the invertebrate innexin gap junction proteins and
are abundantly expressed in the central nervous system [22]. They
possess a similar membrane topology to the connexins consisting
of cytoplasmic N- and C-termini, four transmembrane domains,
two cysteine-containing extracellular loops, and one cytoplasmic
loop [23]. Panx1 is ubiquitously expressed throughout the body,
while Panx2 expression is restricted to the CNS. Despite the similar
membrane topology, the pannexins share little sequence homology
with the connexins and possess only two extracellular loop cyste-
ines instead of three (so does Cx23). Only Panx1 induced large
whole cell membrane currents when expressed in Xenopus oocytes
and was initially reported to mediate intercellular communication
[22]. Hence pannexin channels were called ‘‘hemichannels’’, denot-
ing their similarity to the connexon hemi-gap junction channel, i.e.
connexin hemichannel. Recent evidence disputes the claim that
Panx1 forms functional gap junctions, presumably due to the pres-
ence of an E2 N-linked glycosylation site that is essential to surface
expression [24]. The present day consensus is that the pannexins
do not form functional gap junctions and the hexameric Panx1
membrane channel should, therefore, not be referred to as a hemi-
channel [25].
The P2X(1–7) receptor family form ligand-gated ion channels
that are activated speciﬁcally by ATP (unlike the P2Y G-protein
coupled receptors that are also activated by ADP and other nucle-
otides) [26]. The P2X receptors form non-selective cationic ion
channels that are permeable to Ca2+ and thus contribute to intra-
cellular Ca2+ signaling in response to ATP release. The P2X7 recep-
tor channel is unique among the P2XRs in that it possesses a long
cytoplasmic C-terminal domain that contributes to the formation
of an additional open ‘‘dilated’’ pore state that results in cell per-
meabilization and inﬂux of ﬂuorescent dyes with molecular
weights of 6800 daltons, e.g. YO-PRO-1 [27,28]. Low external diva-
lent cation (e.g. Ca2+ and Mg2+) concentrations potentiate the ATP
activation of P2X7 receptors, but will not activate the channel in
the absence of the agonist [29]. P2X7 receptor activation ﬁrst in-
duces a cationic permeability that excludes large organic cations
like N-methyl-D-glucamine (NMDG) and YO-PRO and subsequently
induces the dilated pore state that dramatically increases large
cation permeability [30]. The trimeric P2X7 receptor subunitpossesses cytoplasmic N- and C-termini, two transmembrane
domains, and one extracellular loop with numerous disulﬁde
bonded cysteine residues. There is speculation that Panx1 medi-
ates the formation of the large pore state of the P2X7 receptor since
Panx1 co-expression, knockdown, or pharmacological blockade
correlated with dye uptake in P2X7 expressing cells [31,32]. Panx1
also co-immunoprecipitates with P2X7 when both proteins are
expressed in HEK cells, although this association was observed
with transient overexpression of an epitope-tagged Panx1 protein
[31]. In contrast, one recent study failed to detect a decrease in cel-
lular dye uptake with Panx1 RNAi silencing or pharmacological
inhibition of prospective connexin hemichannel or Panx1 channels
[33]. Furthermore, structure–function mutagenesis of the P2X7
pore-forming second transmembrane domain increased the
permeability to Cl ions and the anionic dye ﬂuorescein-5-isothio-
cyanate (FITC) while decreasing the permeability of the cationic
ethidium bromide (EtBr) dye of open P2X7[G345C] mutant recep-
tors, consistent with the intrinsic large pore-forming ability of the
P2X7 receptor [34].
Thus, activation of P2X7 and/or Panx1 channels will result in
cell permeabilization, intracellular Ca2+ transients, and uptake of
ﬂuorescent dyes such as ethidium bromide (EtBr), propidium
iodide (PI), Lucifer Yellow (LY), and YO-PRO, as will connexin hemi-
channels (LY permeability will be limited for the weakly cation-
selective connexin hemichannels like Cx40, Cx46, and Cx50 since
LY is anionic). Connexin hemichannel conductances range from
17 to 350 pS depending on the connexin type (e.g. 220 pS for
Cx43) [4], and reports of the Panx1 channel conductance vary from
300 to 475 pS to recent observations of a 70 pS channel [35–38].
A 400–420 pS channel has been described that ﬁts the pharma-
cological proﬁle of the P2X7 receptor permeabilization pore in
macrophages and transfected HEK293 cells [39,40]. Thus, ambigu-
ities about the channel conductances and permeabilities of these
three channel types makes distinguishing between them difﬁcult,
if not impossible.
3. External Ca2+ gating of connexin hemichannels
The typical method for demonstrating the presence of connexin
hemichannels is to voltage clamp connexin-expressing isolated
cells bathed in a divalent-free saline and vary the membrane
potential from negative to positive potentials since low [Ca2+]o
(<1 mM) and positive Vm conditions increases the hemichannel
open probability (Po) [3–5,8,13,14,41]. Native connexin hemichan-
nel Po is signiﬁcantly reduced when [Ca2+]o is elevated to
physiological levels, e.g. 2 mM. Macroscopic current–voltage rela-
tionships (e.g. 80 to +80 mV) and differential high–low [Ca2+]o
whole cell current measurements are routine ways to quantify
putative connexin hemichannel currents. The 50% inhibitory con-
centration constant (IC50) for [Ca2+]o closure of Cx46 hemichannels
expressed in Xenopus oocytes is 380 lM, 5.3 mM for [Mg2+]o, and
may be as low as 100 lM [Ca2+]o for Cx50 hemichannels [5,41].
Intracellular acidiﬁcation also closes Cx46 hemichannels [4,42].
An external Ca2+-gate is thought to minimize connexin hemichan-
nel Po under physiological conditions, though the molecular
identity of the connexin hemichannel calcium gate is still the
subject of intense investigation (e.g. Cx26, Cx46). The external
Ca2+-gate of Cx26 and Cx32 hemichannels is commonly proposed
to be formed from a ring of acidic amino acid residues located on
the connexin extracellular loops (E1 and/or E2) [43,44]. The extra-
cellular location of a connexin hemichannel gate was conﬁrmed by
a substituted cysteine accessibility method (SCAM) experiment
using the thiol-reactive maleimidobutyryl-biocytin (MBB) com-
pound on an L35C mutant Cx46 hemichannel in the presence or
absence of 5 mM [Ca2+]o [45]. Experimental examination of a Char-
cot Marie Tooth disease (CMTX) D178Y Cx32 mutation led to the
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residues form an extracellular binding pocket for six Ca2+ ions that
accounts for the [Ca2+]o sensitivity of Cx32 hemichannels, albeit
with a relatively low IC50 of 1.3 mM [44]. Structure-based molecu-
lar dynamic simulations and experimental site-directed mutagen-
esis of Cx26, particularly of disease-associated mutations,
approaches to connexin hemichannel gating and permeation are
helping to delineate the molecular bases for the differential
[Ca2+]o sensitivities of speciﬁc connexin hemichannels [43,46].
4. Pharmacological blockade of connexin, pannexin, and P2X7
channels
The application of known chemical gap junction channel block-
ers, ﬂuorescent dye uptake assays, and exogenous expression sys-
tems are commonly used to associate a particular connexin with
the presence of an apparent hemichannel current or molecular
(dye/ATP) uptake/release pathway. Chemical classes of gap junc-
tion channel blockers include long-chain alkanols (e.g. heptanol,
octanol), volatile anesthetics (e.g. halothane), long chain cis-unsat-
urated fatty acids and related amides (e.g. oleic acid, oleamide),
glycyrrhizic acid derivatives (18-a/b glycyrrhetinic acid, carbenox-
olone (CBX)), fenamates (e.g. ﬂufenamic acid), and 2-aminophen-
oxyborate [47–56]. Essentially all of these lipophilic compounds
affect the activity of other membrane ion channels or have other
physiological effects which limit their utility as selective gap junc-
tion channel blockers. The antagonist properties of a variety of large
pore channel blockers is summarized by Spray et al. [57], who also
discusses the complexity of distinctly identifying themolecular ori-
gin of plasmalemmal permeabilization pores. CBX is often consid-
ered the best chemical uncoupling agent for cardiac gap junctions
owing to a relative lack of pharmacological effects on the cardiac ac-
tion potential [58]. However, CBX also blocks the recently identiﬁed
pannexin1 channels at lower concentrations (5 lM) than Cx43 gap
junctions, complicating the use of this agent as a pharmacological
identiﬁer of connexin hemichannel activity [56,59]. Selective block-
ade of Panx1 channels is now possible, however, with probenecid or
food dye FD&C Blue #1 (Brilliant Blue FCF, BB FCF) with IC50s of 150
and 0.27 lM, respectively [60,61]. BB FCF may be especially useful
since 100 lM BB FCF had no effect on connexin (Cx32E143, Cx46)
hemichannels or purinergic P2X7 receptor channels, which are
readily activated by benzoylbenzoyl-ATP (BzATP) and inhibited by
oxidized ATP (oATP) [60]. P2X7 receptors are relatively resistant
to the P2 antagonist suramin, are slowly and irreversibly inhibited
by oATP, and are reversibly inhibited by BBG, A740003, and
A438079 [62,63]. Selective pharmacological blockade to distinguish
connexin hemichannels from Panx1 and P2X7 channels is not read-
ily achievable with known chemical gap junction uncoupling
agents. Perhaps the best way to distinguish a P2X7 channel from a
Panx1 channel or connexin hemichannel is by selective pharmaco-
logical blockadewith oATP, A740003, or A438079 for P2X7 channels
and probenecid or BB FCF for Panx1 channels.
Another approach to the ‘‘selective’’ blockade of connexin chan-
nels was the development of ‘‘gap’’ peptides. Gap26 and Gap27
peptides were designed to mimic the extracellular loop 1 and 2
(E1 and E2) connexin domains and prevent gap junction formation
by binding to the undocked connexin hemichannel prior to gap
junction formation [64,65]. These connexin mimetic peptides are
most effective at inhibiting neo-gap junction formation and fail
to inhibit the chimeric Cx32E143 hemichannel activity despite
the presence of the speciﬁc Cx43 E1 and E2 peptide sequences
[66]. The Gap26 and Gap27 peptides partially inhibit Cx43 hemi-
channels, but also pannexin 1 channels [66,67]. Complicating
matters further, a Panx1 mimetic peptide, 10panx1, partially inhib-
its Cx46 hemichannels despite the lack of decameric peptidesequence homology [66]. These Gap26, Gap27, and 10panx peptides
are marketed by commercial vendors. The bottom line is that se-
quence homology, or the lack thereof, is not a reliable predictor
of connexin hemi-, gap junction, or Panx1 channel blocking activ-
ity. However, one recently developed Gap 19 connexin cytoplasmic
loop mimetic peptide has the unique property of inhibiting Cx43
hemichannels without affecting gap junction communication or
Panx1 channel activity [68]. The effect of Gap 19 on P2X7 channels
has not been examined.
5. Exogenous expression systems for the study of connexin
hemichannels
The presence of three molecularly distinct channels capable of
facilitating ATP release, ﬂuorescent dye uptake, and plasmalemmal
Ca2+ permeabilization, along with the knowledge that pharmaco-
logical gap junction blockade, with the possible exception of
Gap19, is poorly selective among P2X7, Panx1, and connexin hemi-
channels creates a dilemma for studying endogenous or exoge-
nously expressed hemichannels. The two most abundant cellular
systems for the exogenous expression of connexins are Xenopus oo-
cytes and communication-deﬁcient cell lines like HeLa or murine
neuro2a (N2a) cells [69–71]. These preparations were originally
developed for the study of newly cloned connexin gap junction
proteins, but have been adapted to the study of connexin hemi-
channels since the concept of their existence emerged [3]. Xenopus
oocytes express an endogenous connexin38, similar to mammalian
Cx37, that is capable of heterogeneous coupling with Cx43 and
other connexins and must, therefore, be knocked down with
Cx38 antisense RNA injections prior to injection of the connexin
mRNA to be studied [72]. HeLa cells exhibit a low level of endoge-
nous gap junction coupling, presumably mediated by Cx45, which
may complicate interpretation of connexin-speciﬁc functional gap
junction interactions [73,74]. N2a cells are essentially devoid of
endogenous connexin expression [70], but reportedly express
Panx1 and P2X7 [75,76].
Another mammalian cell line that is gaining in popularity, par-
ticularly for the biophysical study of Panx1 channels, is human
embryonic kidney 293 (HEK293), and their SV40 large T antigen
transfected variant, HEK293T, cells. The HEK293 cell line is com-
monly used for functional studies of exogenously expressed ion
channels and receptors and only infrequently utilized for gap junc-
tion studies, e.g. hemichannel function of Cx26 and Cx30 deafness
mutations [77–79]. Biophysical studies in HEK293T cells have
demonstrated that Panx1 channels are activated by C-terminal cas-
pase cleavage of an auto-inhibitory domain, even in the presence of
2 mM [Ca2+]o and [Mg2+]o, or inhibited by S-nitrosylation [80,81].
Although the original source of these cells is the American Type
Culture Collection (ATCC) accession code CRL-1573, there are con-
ﬂicting reports about the immunoreactive expression of Cx43 in
HEK293 cells [82,83]. Despite the inability to detect Cx43 gap junc-
tions byWestern blot or immunohistochemical staining in HEK293
cells, low levels of endogenous electrical coupling have been
recorded [83–85]. Stong et al. [78] reported that the HEK293 cell
line lacks endogenous connexin expression, citing a methods
chapter on exogenous connexin expression in mammalian cells
[86], although the cited work made reference to HeLa cells, not
HEK293 cells, and no connexin immunoblots were performed on
HEK293 cells until later [82,83]. Since electrical coupling and
Cx43 immunolabeling has been detected in HEK293 cells, endoge-
nous connexin expression in HEK293 cells should not be consid-
ered null. HEK293 cells do not endogenously express P2X7
receptor channels although they reportedly express Panx1 [87,88].
This laboratory tested a population of HEK293T cells in the
1990s and recently tested HEK293 cells obtained from two different
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Fig. 1. (A) An immunoblot for Cx43 showing a variable amount of endogenous Cx43
expression in HEK293 cells obtained from two different research laboratories. (B)
An immunoblot for Cx43 from the low Cx43 expressing HEK293-2 cells, a stable
clone (80-1) of the same cell line after knockdown of Cx43 with an anti-Cx43
shRNA, and a scrambled control shRNA. Tubulin was used as a loading control. (C)
Quantiﬁcation of the relative Cx43 expression levels from the HEK-2 cells, the Cx43
shRNA HEK-2 cell clone, and the scrambled shRNA control from three immunoblots
like the one displayed in panel B. (D) Anti-Cx43 antibody (Millipore #AB1728) was
immunolocalized in HEK-2 cells with an Alexa Fluor555 conjugated secondary









































































































gj = 5.9 nS
D
Fig. 2. (A) A whole cell patch clamp recordings from an HEK293-2 cell during
repeated runs of a 40 to +30 mV voltage step under low (nominally zero) [Ca2+]o
conditions. Activation of a membrane channel that remained open upon return to
40 mV was frequently evident. (B) A whole cell recording from the same HEK-2
cell after the addition of 2 mM CaCl2 to the bath saline illustrates the reduction in
observed endogenous channel activity. (C) Ensemble averages of the ﬁve current
traces displayed in panels A and B illustrating the difference in whole cell currents
between 0 and 2 mM [Ca2+]o. (D) The junctional current–voltage relationship
acquired from this HEK-2 cell coupled to a partner HEK-2 cell via Cx43 gap
junctions. The ratio of [Ca2+]o-sensitive non-junctional membrane current to gap
junction current was 0.04 in this HEK-2 cell pair.
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measurable levels of electrical coupling were always detected.
The level of Cx43 expression may vary dependent on the source
of the HEK293 cells after decades of culturing, yet high levels of
gap junction conductance (gj) were readily measured even in the
lower Cx43 expressing variety of HEK293 cells we have assayed
(HEK-2). We attempted to knockdown the endogenous Cx43
expression by stable transfection with a shRNA construct directed
against human Cx43 (Origene HuSH-29 #SKU-TR312771; human
GJA1 29mer shRNA). Four different Cx43 shRNA constructs and
one scrambled shRNA control were transfected into HEK293-2 cells
and fourteen Cx43 and two control shRNA stable clones were se-
lected with puromycin (2 lg/ml). Clones were immunoblotted for
Cx43 protein with tubulin as a loading control as previously de-
scribed [89]. Representative Western blots of WT HEK293-2, the
best Cx43 shRNA clone (#80-1), and one scrambled control are pre-
sented in Fig. 1B. These Western blot experiments were performed
in triplicate and Cx43 protein levels were quantiﬁed by densitome-
try scans and the Cx43 shRNA construct reduced Cx43 protein
expression by 76% relative to wild-type HEK293-2 cells (Fig. 1C).
ANOVA analysis indicated that mean Cx43 relative expression lev-
els were not signiﬁcantly different (F-value = 0.08). We measured
the gj values in HEK-2 and the selected Cx43 shRNA HEK293
#80-1 cell pairs by conventional double whole cell patch clamp
techniques, corrected for junctional series resistance errors as pre-
viously described [90], and the average gj values measured
33.9 ± 10.8 nS, n = 6 for the untransfected HEK-2 cells and
3.6 ± 0.7 nS, n = 7 for the Cx43 shRNA knockdown #80-1 cells. Thus,
despite a 3/4 decrease in Cx43 expression and a 90% reduction in gj,
wewere not able to generate a HEK293 cell clone that was devoid of
endogenous Cx43 expression and electrical coupling. Gap junction
plaques could be detected as small puncta by immunocytochemical
methods between cultured wild-type HEK293-2 cells (Fig. 1D).
6. Relative preference of a connexin to form hemichannels or
gap junctions
Typically connexin hemichannels are studied in isolated cells,
which biases the system in favor of hemichannel formation sincethe lack of cell–cell contact prevents existing hemichannels from
docking to form functional gap junctions. The ability of a particular
connexin to form gap junctions instead of hemichannels is rarely
considered in the same preparation. John et al. [14] stated that
‘‘we cannot absolutely exclude that hemichannel density in iso-
lated myocytes is increased by the isolation procedure’’. A struc-
tural study of lens Cx50 suggests that there are at least 10-fold
more gap junction channels than hemichannels in lens ﬁber cells
[7,91]. Since connexin hemichannels are generally sensitive to
[Ca2+]o, we measured the Ca2+-sensitive non-junctional membrane
currents and gap junction currents (Ij) in paired HEK293-2 cells
and the Cx43 shRNA knockdown #80-1 clone. At least one pre-
sumed Cx43 hemichannel was evident during whole cell current
recordings from an HEK293-2 cell in 0 mM [Ca2+]o saline during
the activating voltage step pulse from 40 to +30 mV (upward ar-
row) that sometimes remained open after stepping the membrane
potential back to 40 mV (downward arrow) (Fig. 2A). After addi-
tion of 2 mM CaCl2 to the bath, the observed hemichannel activity
decreased (Fig. 2B) and the ensemble averaged currents revealed a
decrease in whole cell current of 15.8 pA during the 40/+30/
40 mV pulse protocol (Fig. 2C). A similar 14.9 pA current decrease
was seen with the addition of 2 mM [Ca2+]o in the partner cell (data
not shown). By comparison, the slope gap junctional conductance
(gj) of this wild-type HEK293-2 cell pair during a ± 120 mV Vj ramp
measured 5.9 nS, >25 times higher than the Ca2+-sensitive mem-
brane conductance of 225 pS. Assuming a Cx43 hemichannel con-
ductance (cHC) of 220 pS and a Cx43 gap junction channel
conductance (cj) of 110 pS, these values correspond to a single
open Cx43 hemichannel and 54 gap junction channels in this
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0.85 ± 0.49 nS (mean ± S.E.M., n = 12) in the HEK293-2 cells and
0.38 ± 0.16 nS in the #80-1 cells (n = 10). By comparison, the gj val-
ues were 40 and 10 times higher than the endogenous [Ca2+]o-sen-
sitive whole cell current in these HEK and 80-1 cells. If one factors
in the respective Cx43 gap junction channel and hemichannel con-
ductances (cj and cHC) of 110 and 220 pS [4], then the approximate
gap junction channel to hemichannel ratio is between 20 and 80.
This means that only 1.25–5% of the Cx43 channels exist as hemi-
channels. A 1% occurrence of Cx43 hemichannels in an adult ven-
tricular cardiomyocyte containing approximately 10000 open gap
junction channels (gj  1 lS, [92]) suggests that a cardiomyocyte
may contain a hundred hemichannels, more than enough to cause
Na+ and Ca2+ overloading and membrane depolarization if acti-
vated [14].
Perhaps the best evidence for abberant mutant connexin hemi-
channel activity being the primary cause of a disease pathology is
the Cx26 G45E mutation. The Cx26 G45E mutation was identiﬁed
in patients with hereditary hearing loss and keratitis-ichthyosis-
deafness syndrome (KIDS) and, when expressed Xenopus oocytes
or HEK cells, induced hemichannel currents and cell death
[18,78,93,94]. The mechanistic basis for the cellular death induced
by the Cx26 G45E mutation appears to be the increased Ca2+ per-
meability of the mutant hemichannel, not a decrease in the
[Ca2+]o-sensitive gating of the hemichannel as observed with the
A40V mutation [95]. A mouse model of the Cx26 G45E mutation
was generated that recapitulated numerous symptoms of KIDS,
thus providing a pathophysiological link for this abberant Cx26
hemichannel mutation to the human disease condition [96]. The
functional data acquired using this molecule-to-mouse approach
provides the strongest evidence that the aberrant hemichannel
activity and Ca2+ permeability of the Cx26 G45Emutation is the ba-
sis for the disease pathologies associated with KIDS.7. Concluding remarks
Connexins are capable of forming hemichannels that are char-
acterized by possessing a cHC twice that of the measured cj of their
respective homomeric gap junction channels, are permeable to
monovalent cations, Ca2+, ATP4, metabolites, ﬂuorescent dyes
and molecules up to 500–1000 Da in molecular weight, are sensi-
tive to the usual lipophilic gap junction uncouplers and cytoplas-
mic acidiﬁcation, and increase their open probability with
submillimolar [Ca2+]o, positive membrane potentials, and meta-
bolic inhibition. Panx1 channels and P2X7 receptor channels exist
in many cell types and distinguishing between them and connexin
hemichannels is difﬁcult since they may possess similar non-selec-
tive cation conductances and molecular permeabilities to Ca2+,
ATP4, and ﬂuorescent dyes like YO-PRO. Panx1 and connexin
hemichannels possess overlapping sensitivities to CBX and mi-
metic peptides despite the lack of sequence homology, with the
possible exception of Gap19 which blocks Cx43 hemichannels
but not gap junctions. Panx1 channels are not gated by [Ca2+]o,
are activated by caspase-dependent proteolytic cleavage, inhibited
by S-nitrosylation, and apparently do not form gap junctions owing
to glycosylation of their second extracellular loop. P2X7 channels
are also not activated by low [Ca2+]o, but their sensitivity to the
natural ATP agonist is enhanced by low external divalent cation
concentrations. Perhaps the best way to distinguish between conn-
exin hemichannels and Panx1 or P2X7 channels is pharmacologi-
cally since Panx1 channels are speciﬁcally inhibited by
probenecid and the FD&C Blue #1 (Brilliant Blue FCF, BB FCF) and
Brilliant Blue G (BBG) dyes with micromolar and nanomolar sensi-
tivities, respectively. P2X7 channels may also be inhibited by BBG,
but are selectively activated by (benzoly)benzoyl ATP (BzATP),reversibly inhibited by A740003 and A438079, and slowly and irre-
versibly inhibited oxidized ATP (oATP). Many immune and neuro-
nal cell types express connexins, pannexins, and purinergic
receptors. So mammalian cell lines used to exogenously express
and electrophysiologically study any one of these channels should
be screened for endogenous connexin (e.g. Cx43), Panx1, and P2X7
protein expression by real-time PCR and immunoblot assays.
Immunohistochemical labeling of cells to detect the presence of
gap junctions is the least sensitive assay and may not detect the
presence of Cx43 despite an abundance of electrical coupling in
HEK293 cells as an example. Electrophysiological assays like patch
clamp channel or whole cell voltage clamp recordings are the most
sensitive assays since these approaches are able to detect a single
open channel. Finally, we estimate that only 1–5% of the wild-type
hexameric connexin oligomers exists as a function hemichannel,
relative to the abundance of gap junction channels found in those
same cells, and that studying connexin hemichannels in isolated
cells biases the results in favor of hemichannel formation and
may overestimate the functional relevance of their activity in an
artiﬁcial system where gap junction formation is not possible.
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